Aaron S. Mansfield, M.D. - Doctors and ...

Dr. Aaron S Mansfield, MD

Claim this profile

Mayo Clinic in Rochester

Studies Cancer
Studies Pancreatic Cancer
9 reported clinical trials
35 drugs studied

Area of expertise

1

Cancer

Aaron S Mansfield, MD has run 5 trials for Cancer. Some of their research focus areas include:

Stage IV
KRAS positive
Stage III
2

Pancreatic Cancer

Aaron S Mansfield, MD has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:

Stage IV
KRAS positive
Stage III

Affiliated Hospitals

Image of trial facility.

Mayo Clinic In Rochester

Image of trial facility.

Mayo Clinic Hospital In Arizona

Clinical Trials Aaron S Mansfield, MD is currently running

Image of trial facility.

Pre-Surgery Immunotherapy

for Mesothelioma

This trial tests if giving immunotherapy drugs can better control disease in patients with a specific type of mesothelioma. The drugs help the immune system attack cancer cells, which may stop the cancer from growing and spreading.

Recruiting

1 award

Phase 2

27 criteria

Image of trial facility.

Chemotherapy + Immunotherapy

for Mesothelioma

This phase II trial compares the usual treatment alone (carboplatin, pemetrexed, and bevacizumab) to using immunotherapy (atezolizumab) plus the usual treatment in treating patients with peritoneal mesothelioma. The usual treatment consists of surgery or chemotherapy. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid and may kill cancer cells. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving atezolizumab with usual treatment may work better than usual treatment alone.

Recruiting

1 award

Phase 2

36 criteria

More about Aaron S Mansfield, MD

Clinical Trial Related

1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 5 Active Clinical Trials

Treatments Aaron S Mansfield, MD has experience with

  • Biospecimen Collection
  • Paclitaxel
  • Sotorasib
  • Ipatasertib
  • Atezolizumab
  • Bevacizumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Aaron S Mansfield, MD specialize in?

Is Aaron S Mansfield, MD currently recruiting for clinical trials?

Are there any treatments that Aaron S Mansfield, MD has studied deeply?

What is the best way to schedule an appointment with Aaron S Mansfield, MD?

What is the office address of Aaron S Mansfield, MD?

Is there any support for travel costs?